Alarm Treatment for Combined Enuresis and Daytime Urinary Incontinence in Children
NCT ID: NCT04260646
Last Updated: 2024-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
89 participants
INTERVENTIONAL
2017-05-01
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Timed Awakening in Treatment of Enuresis
NCT06586476
Sleep and Nocturnal Enuresis: Ambulatory Polysomnographic Study
NCT03477812
Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children
NCT05989646
Programmable Timer in the Bladder Rehabilitation Treatment of OAB
NCT00238680
Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis
NCT07108062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At present DUI is treated first with urotherapi, if insufficient bladder modulating drugs are added. When daytime continence is achieved, the enuresis is handled using (in cases of small bladder capacity) an enuresis alarm.
Whether daytime continence is a prerequisite for treating NE or whether enuresis alarm may positively influence DUI treatment has not been studies in a RCT previously.
The aim of this study is to examine whether alarm therapy in addition to urotherapy can have a beneficial effect in treating children with combined daytime incontinence and enuresis. Thus the hypothesis are:
1. That the enuresis alarm therapy is beneficial in DUI treatment.
2. That it is possible to treat enuresis before daytime continence has been achieved
Methods: The study is a randomized controlled trial. The participants will be approx. 90 children that suffers from combined enuresis and daytime urinary incontinence. The participants will be equally randomized to 8 week of timer watch assisted urotherapy 1) with or 2) without addition of enuresis alarm treatment. The study includes 3 outpatient visits and 2 phone contacts.
The participants will complete bladder diaries as well as drypie and nocturnal urine production registrations. Also registrations on number and time of enuresis will be recorded for the alarm group children. All children will be provided a timer watch.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Urotherapy without enuresis alarm
Standard urotherapy inclunding normalized fluid intake and times voidings. The timed voiding regime of every 2 hours will be assisted by a timer Watch.
Timer watch (Rodger)
Timer watch (Rodger) vibrating or sounding alarm for remembering timed voiding intervals
Standard Urotherapy with enuresis alarm
Standard urotherapy inclunding normalized fluid intake and times voidings. The timed voiding regime of every 2 hours will be assisted by a timer Watch. In addition an enuresis alarm will be provided and worn by the participants during the night.
Enuresis Alarm Rodger and Timer watch (Rodger)
Nocturnal enuresis fluid sensitive alarm and Timer watch (Rodger) vibrating or sounding alarm for remembering timed voiding intervals
Timer watch (Rodger)
Timer watch (Rodger) vibrating or sounding alarm for remembering timed voiding intervals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Enuresis Alarm Rodger and Timer watch (Rodger)
Nocturnal enuresis fluid sensitive alarm and Timer watch (Rodger) vibrating or sounding alarm for remembering timed voiding intervals
Timer watch (Rodger)
Timer watch (Rodger) vibrating or sounding alarm for remembering timed voiding intervals
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completed "Tørfisk" (Danish version of the Bower "Dry pie" Incontinence diary 1) and bladder diary (containing frequency and volume of voiding, fluid intake through 48 hours as well as 7 days night registering of nocturnal urine production (NUP) and wet nights.)
* A minimum of 2 wet days per week
* A minimum of 2 wet nights per week.
* Average NUP (aNUP) on wet nights of less than 130 % of expected bladder capacity (EBC=30\*(age+1))
* Obtained oral and written informed consent from the participant and both custody holders.
Exclusion Criteria
* Ongoing urinary tracts infection (UTI)
* Ongoing obstipation defined by ROM IV criteria
* Glycosuria or proteinuria
* Previously received treatment with anticholinergics
* Previously received treatment with enuresis alarm
* Sign on neurological or structural cause of the incontinence
* Reduced compliance for alarm treatment defined as use of the alarm less than 80 % of the nights of the treatment period.
5 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
Regional Hospital West Jutland
OTHER
Regionshospital Nordjylland
OTHER_GOV
Aalborg University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Søren Hagstrøm, MD PhD
Consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept pediatrics, Aalborg University Hospital
Aalborg, , Denmark
dept Pediatrics, Aarhus University Hospital
Aarhus N, , Denmark
Børneafdelingen, Herning
Herning, , Denmark
Dept pediatrics, North Denmark Regional Hospital Hjoerring Hjoerring
Hjørring, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-20170005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.